Hematologic Malignancy
230
64
79
78
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
35 trials with published results (15%)
Research Maturity
78 completed trials (34% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
8.7%
20 terminated out of 230 trials
79.6%
-7.0% vs benchmark
5%
12 trials in Phase 3/4
45%
35 of 78 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 78 completed trials
Clinical Trials (230)
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Telerehabilitation in Hemato-oncological Survivors
A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Expressive Writing Program Among Young Adults With Blood Cancer
Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO)
A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Mosaic Trial for Stem Cell Transplant Recipients
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
Hospital at Home at EOL in Heme Malignancies
VitalTraq for the Detection of CRS